Wallstreetbets

The Bitcoin miners all had a great day on Wednesday as Bitcoin has stabilized around $55,000 and COIN around $300. MARA, RIOT and NCTY all had rebounds in the 10% range. Call options remain the best play on these stocks in order to try to create a gamma squeeze on the shorts and option writers.  But one miner that is falling under the radar and has the greatest upside is SPRT. Like the other Bitcoin miners it was up about 10% today, closing at its day high of $4.02. It should be trading in the $8 area just to come in line with the valuation of other Bitcoin mining stocks, and higher if they move back up to their 52-week highs as Bitcoin rises again. SPRT signed a deal to merge with Greenidge, a Bitcoin miner with its own source of power. The Greenidge presentation shows how it is comparable or superior to other top publicly traded Bitcoin miners out there: There are two articles on Seeking Alpha about this deal, both of which calculate a 2-3x upside for SPRT just to come in line with R

COIN started trading yesterday. That's leading to the Bitcoin miners losing some steam despite Bitcoin remaining strong at over $62,000. We think that MARA, RIOT and NCTY are due for a big rebound. NCTY just raised $6.7 million at an ADS price of $24.81 to buy more Bitcoin mining machines, so the stock being under $20 is a great deal for buyers. The $20 call options expiring tomorrow offer the biggest high risk upside as well as the MARA $40 calls and RIOT $45 calls. We purchased all three call options this afternoon. A major run into the call options could cause a squeeze similar to the one we saw on GME leading into option expiry as option writers are forced to cover their position in-the-money tomorrow.  But one miner that is falling under the radar and has the greatest upside is SPRT. It should be trading in the $10 area to come in line with the other Bitcoin mining stocks. SPRT signed a deal to merge with Greenidge, a Bitcoin miner with its own source of power. The Greenidge p

 It's time for WSB retards to give up on the dream of AMC ever going anywhere. It's not like GME. They are hoping that AMC will go up, but it already has gone up a lot by market cap. The chart below shows in the last six months that AMC's stock price has gone up 150%, but its market cap has gone up 919%. Why is this? Because AMC's shares outstanding have gone up from about 120 million to 450 million during that time. Shorters aren't selling you shares cheaply, it's AMC's own management that is selling you shares. We have seen people upset about the vote to increase the authorized shares to over one billion from 500 million. They are angry at management. But why would you want to invest in a company that is actively working against shareholder interests? AMC management will get its way and will use the stock as currency to pay their own expenses. They don't care about shareholders or the stock price. It's a complete waste of time and money to be diamo

DeepFuckingValue, also known as Roaring Kitty, is the prolific GME investor who has led the shorting squeeze charge. A  Reddit poster recently broke down his top picks  outside of GME, as shown in an image of his notebook: The one that stands out the most is HGEN. At the time of this note, HGEN was $19.59. It closed yesterday at $16.92, below this price and the price of the $18.50 offering it just closed on Monday. HGEN announced Positive Phase 3 Topline Results Demonstrating That Lenzilumab™ Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19. The stock shot up to $29 on a short squeeze fueled rally after the news but pulled back as the company raised the $92.5 million.  Usually investors view financing as bad news, but this is done with a distinct purpose. The company is going to be manufacturing Lenzilumab in advance of expected Emergency Use Authorization granted by the FDA. The timing of this grant is expected to happen in weeks, so spe

DeepFuckingValue, also known as Roaring Kitty, is the prolific GME investor who has led the shorting squeeze charge. A  Reddit poster recently broke down his top picks  outside of GME, as shown in an image of his notebook: The one that stands out the most is HGEN. At the time of this note, HGEN was $19.59. It closed today at $17.74, below this price and the price of the $18.50 offering it just closed on Monday. HGEN announced Positive Phase 3 Topline Results Demonstrating That Lenzilumab™ Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19. The stock shot up to $29 on a short squeeze fueled rally after the news but pulled back as the company raised the $92.5 million.  Usually investors view financing as bad news, but this is done with a distinct purpose. The company is going to be manufacturing Lenzilumab in advance of expected Emergency Use Authorization granted by the FDA. The timing of this grant is expected to happen in weeks, so specula

DeepFuckingValue, also known as Roaring Kitty, is the prolific GME investor who has led the shorting squeeze charge. A Reddit poster recently broke down his top picks outside of GME, as shown in an image of his notebook: The one that stands out the most is HGEN. At the time of this note, HGEN was $19.59, trading slightly above where it is today. But the key difference being between now and last month is that HGEN announced Positive Phase 3 Topline Results Demonstrating That Lenzilumab™ Improves Survival Without Need for Mechanical Ventilation in Hospitalized Patients With COVID-19. The stock shot up to $29 on a short squeeze fueled rally after the news but pulled back as the company got 5 million shares of financing at $18.50 to raise $92.5 million.  Usually investors view financing as bad news, but this is done with a distinct purpose. The company is going to be manufacturing Lenzilumab in advance of expected Emergency Use Authorization granted by the FDA. The timing of this grant is